Research Catalog

Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

Title
Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Publication
  • Washington : U.S. Government Publishing Office, 2015.
  • Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office

Details

Description
iv, 217 pages; 24 cm
Subject
  • Drugs of abuse > Law and legislation > United States
  • Drugs > Law and legislation > United States
  • Drug approval > United States
  • Drug accessibility > United States
Note
  • Shipping list no.: 2015-0324-M.
  • "Serial No. 113-147."
Bibliography (note)
  • Includes bibliographical references.
Reproduction (note)
  • Microfiche.
Call Number
GPO Microfiche Y 4.C 73/8:113-137
OCLC
marcive932070200
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author.
Title
Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.
Publisher
Washington : U.S. Government Publishing Office, 2015.
Distributor
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Type of Content
text
Type of Medium
microform
Type of Carrier
microfiche
Bibliography
Includes bibliographical references.
Reproduction
Microfiche. [Washington, D.C.] : U.S. Government Publishing Office, [2015] 3 microfiches : negative.
Other Form:
Print version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation (DLC) 2015461367 (OCoLC)917503036
Online version: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health. Improving predictability and transparency in DEA and FDA regulation (OCoLC)914355788
Gpo Item No.
1019-B-01 (MF)
Sudoc No.
Y 4.C 73/8:113-137
View in Legacy Catalog